Lena Åredal on February 13, through the company Årle, bought 329,113 shares in the medical technology company Synthetic MR, where she is CEO. The shares were purchased at a price of SEK 1.21 per share, a transaction of SEK 398,200. The transaction was carried out outside a trading venue. This is evident from Finansinspektionen's insider register.Åredal thereafter owns 468,583 shares in Synthetic MR, according to the ownership service Holdings. She assumed the role of CEO in September 2025.